--GSK PLC is due to appoint Julie Brown as its next chief financial officer, succeeding Iain Mackay, Sky News reports.
--The pharmaceutical giant is expected to announce Ms. Brown's appointment as early as Monday, Sky reports.
Full story: https://bit.ly/3DTUWIc
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
09-26-22 0201ET
Currently, Julie Brown occupies the position of Director, Chief Operating & Financial Officer at Burberry Group Plc. Ms. Brown is also on the board of Roche Holding AG and F. Hoffmann-La Roche Ltd. and Member of Taxation Institute of London and Member of Institute of Chartered Accountants in England & Wales. In her past career Ms. Brown occupied the position of Chief Financial Officer & Executive Director at Smith & Nephew Plc, Chief Financial Officer at AstraZeneca Plc Head-Finance Department at Zeneca and Head-Marketing at Astrazeneca Produtos Farmaceuticos Ltda (both are subsidiaries of AstraZeneca Plc) and Manager-Licensing & Commercial Finance at Imperial Chemical Industries Ltd. She received an undergraduate degree from the University of Warwick.
View full profile| Linked companies | |
|---|---|
| GSK PLC | Director of Finance/CFO |
